Related by context. Frequent words. (Click for all words.) 68 Cardiovascular Devices 64 Dental Devices 63 vitro diagnostics 63 Pipeline Analysis 61 Patient Monitoring 60 Drug Delivery 60 Diagnostic Devices 59 molecular diagnostics 59 Monoclonal Antibodies 58 Opportunities Analysis 58 vitro diagnostic 57 Molecular Diagnostics 57 AbD Serotec 57 Biopharmaceuticals 57 Genetic Testing 56 Repligen Corporation 56 Clinical Trial Results 56 Biomarker 55 DNA Sequencing 55 China Aoxing Pharmaceutical 55 Radiopharmaceuticals 55 FDA Clearance 55 Abbott Molecular 55 Clinical Diagnostics 54 Idera Pharmaceuticals 54 Chemokine Therapeutics 54 Clinical Trials 54 Analgesics 54 Small Molecule 54 IVD 54 Ceragenix 54 BioSpecifics Technologies Corp. 54 Equipment Deals 53 theranostics 53 Hepatitis C Virus 53 XTENT 53 Xenomics 53 Monoclonal Antibody 53 Non Invasive 53 Drug Candidate 53 Biopharma 53 Product Pipeline 53 Biocides 53 biopharmaceuticals 53 Genedata 53 Response Genetics 53 Pharmion Corporation 53 Celsion Corporation 53 Reportlinker 53 oncology therapeutics 53 Idenix Pharmaceuticals 53 Drug Pipeline 53 MicroRNA 53 Stemedica 53 Oncology Drug 53 Biomarker Discovery 52 NASDAQ CRXL 52 Paladin Labs 52 Competitive Analysis 52 Cancer Vaccine 52 ophthalmic pharmaceutical 52 Phase III Trial 52 molecular diagnostic 52 Markets www.researchandmarkets.com/reports/c# 52 Immunomedics Inc. 52 Nymox Pharmaceutical Corporation 52 Merck KGaA Darmstadt Germany 52 Savory Snacks 52 Report companiesandmarkets.com adds 52 Encysive Pharmaceuticals 52 Progenics Pharmaceuticals 52 Detailed Product 52 Immunoassay 52 Phase III Clinical Trial 52 vitro diagnostic tests 52 LeMaitre Vascular 52 Regulus Therapeutics 52 PsychoGenics 52 Applied NeuroSolutions 52 Kensey Nash Corporation 52 Terumo Corporation 52 Nippon Kayaku 52 VIA Pharmaceuticals 52 Rosetta Genomics Ltd. 51 Drug Eluting Stent 51 Cardiac Rhythm Management 51 Helsinn 51 Reagents 51 therapeutic monoclonal antibodies 51 Drug Discovery 51 Loramyc ® 51 Medistem 51 Generex Biotechnology 51 Response Genetics Inc. 51 Pivotal Phase III 51 Ore Pharmaceuticals 51 Completes Enrollment 51 Ikonisys 51 R bortezomib 51 Rexahn Pharmaceuticals 51 ImmunoGen Inc.